Providence Regional Medical Center Everett is a full-service medical center and the flagship hospital of Providence Health & Services, the largest faith-based healthcare system in the Northwestern United States.

During the past decade, Providence Regional Medical Center Everett conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 30 clinical trials were completed, i.e. on average, 63.8% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 19 clinical trials were completed. i.e. 95% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Providence Regional Medical Center Everett" #1 sponsor was "Abbott Medical Devices" with 6 trials, followed by "Boston Scientific Corporation" with 6 trials sponsored, "Gilead Sciences" with 6 trials sponsored, "Cancer Insight, LLC" with 3 trials sponsored and "Boehringer Ingelheim" with 3 trials sponsored. Other sponsors include 40 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Regional Medical Center Everett" #1 collaborator was "Genentech, Inc." with 3 trials as a collaborator, "Elios Therapeutics, LLC" with 2 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 2 trials as a collaborator, "Patient-Centered Outcomes Research Institute" with 2 trials as a collaborator and "Sellas Life Sciences Group" with 2 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Providence Regional Medical Center Everett" are "COVID-19" (7 trials), "Coronary Artery Disease" (5 trials), "Breast Cancer" (4 trials), "Heart Failure" (3 trials) and "Atrial Fibrillation" (2 trials). Many other conditions were trialed in "Providence Regional Medical Center Everett" in a lesser frequency.

Most popular intervention types in "Providence Regional Medical Center Everett" are "Drug" (40 trials), "Device" (20 trials), "Biological" (4 trials), "Behavioral" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Remdesivir" (3 trials), "GM-CSF" (2 trials), "NeuVax vaccine" (2 trials) and "Standard of Care" (2 trials). Other intervention names were less common.

The vast majority of trials in "Providence Regional Medical Center Everett" are 64 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Providence Regional Medical Center Everett". undefined are not yet recruiting, 9 are recruiting, 10 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 36 completed trials in Providence Regional Medical Center Everett, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Providence Regional Medical Center Everett, 4 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 16 trials that are defined as “Not Applicable".

Providence Regional Medical Center Everett has several departments that took part in Clinical trials: "Providence Regional Cancer Partnership" - 244 trials